⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MBOT News
Microbot Medical, Inc. Common Stock
Form 8-K
sec.gov
MBOT
Microbot Medical®’s LIBERTY® Endovascular Robotic System Continues to Expand Market Visibility; Being Featured at an Industry Leading Innovation Conference
globenewswire.com
MBOT
Microbot Medical®’s LIBERTY® Endovascular Robotic System Highlighted at a Leading Vascular Disease Management Conference
globenewswire.com
MBOT
Microbot Medical® to Leverage Current Users Experience of the LIBERTY® Endovascular Robotic System at Key Oncology Conference to Support Commercial Adoption
globenewswire.com
MBOT
Microbot Medical Continues its 2025 Momentum; Announces Key 2026 Milestones
globenewswire.com
MBOT
Microbot Medical® Announces Emory University Hospital as the First Hospital in the World to Adopt the New LIBERTY® Endovascular Robotic System
globenewswire.com
MBOT
Microbot Medical® Commences the Limited Market Release of its LIBERTY® Endovascular Robotic System in the U.S.
globenewswire.com
MBOT
Microbot Medical® to Commercially Debut the LIBERTY® System at The Symposium on Clinical Interventional Oncology Annual Meeting
globenewswire.com
MBOT
Microbot Medical® Secures U.S. Based Logistics Partner to Support the Commercialization of Its LIBERTY® Endovascular Robotic System
globenewswire.com
MBOT
Microbot Medical Announces Final Closing of Exercise of Outstanding Preferred Investment Options of Up to $92.2 Million in Gross Proceeds
globenewswire.com
MBOT